Introduction: Inguinal Lymph node dissection (ILND) has an important role in both staging and treatment of penile cancer. Current data suggest that video endoscopic inguinal lymphadenectomy (VEIL) and Robotic video endoscopic inguinal lymphnode dissection (RVEIL) are feasible and safe with minimal intra-operative complications. There are scarcity of data in Post chemotherapy Robotic VEIL. Perhaps the strongest appeal for its use in post chemotherapy setting is its faster post-operative recovery and less post-operative complications. When compared to open technique, VEIL and RVEIL have similar dissected nodal count, a surrogate metric for oncological adequacy, and a none-inferior inguinal recurrence rate.
Methods: We retrospectively evaluated post chemotherapy patients with penile cancer who underwent RVEIL. Total number of patients were 6, with 12 groins, operated from 2016 to 2021.
Results: The average console time was 153mins (excluding Pelvic Lymph node dissection) and average Lymph node yield was 14. The mean blood loss was 30ml with 2 post operative lymph collection.
Conclusions: The video illustrates the technique of RVEIL in Post chemotherapy penile cancer patients. It demonstrates port site marking, finger dissection to create space beneath sub scarpa's fascia, ports insertion and step by step approach of Inguinal dissection. Even in the post chemotherapy settings, the technique is safe, feasible and easily reproducible.